The purpose of this study is to learn about dacomitinib for the possible treatment of lung cancer.
This study is seeking participants who:
Closest Location
Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.
Condition
Lung Cancer
Sex
Male or Female
Age
18+ years